Quantcast

Latest Daiichi Sankyo Stories

2014-03-28 12:26:05

DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/3vpmvj/investigation) has announced the addition of the "Investigation Report on China's Olmesartan Market, 2009-2018" [http://www.researchandmarkets.com/research/3vpmvj/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) According to statistics from WHO, one-third of the world's adults have high blood...

2014-03-27 12:29:46

DUBLIN, Mar. 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/6x67r4/global ) has announced the addition of the "Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) 2014 will be marked as a transition year for the Japanese Pharma industry - the year is bound to be painful both for innovators and generic companies due to the new regulations. The...

2014-03-26 23:32:34

Pharmica Consulting, the industry leader in life science processes and technology, is pleased to announce that Teresa Faria and James McGurk of Daiichi Sankyo will speak at Pharmica’s SharePoint Conference for the Life Sciences Industry on June 4th and 5th in Plymouth Meeting, PA. Plymouth Meetig, PA (PRWEB) March 26, 2014 As part of its continued service to the industry, Pharmica will host its 10th SharePoint conference in Plymouth Meeting, PA on June 4-5, 2014. The two day conference...

2014-03-19 00:22:17

TOKYO, March 19, 2014 /PRNewswire/ -- Astellas Pharma Inc. ("Astellas"; Tokyo: 4503; President and CEO: Yoshihiko Hatanaka) and Daiichi Sankyo Company, Limited ("Daiichi Sankyo," President and CEO: Joji Nakayama) today announced the companies would form a compound library sharing partnership for approximately 400,000 selected compounds. The collaboration enables each party to promote innovative new medicine research and development. This is the first time that a compound library...

2014-03-05 12:27:04

DUBLIN, March 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/w2749d/antibody_drug) has announced the addition of the "Antibody Drug Conjugates: Contract Manufacturing Market, 2014 - 2024" [http://www.researchandmarkets.com/research/w2749d/antibody_drug ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The concept of Antibody drug conjugates (ADCs) is simple - a cytotoxic /...

2014-02-12 12:32:49

Pharmacist Partners is pleased to announce its participation in PanAgora Pharma's upcoming Customer Experience Summit March 5-6, 2014 in Princeton, NJ. NEW YORK, Feb. 12, 2014 /PRNewswire-iReach/ -- Pharmacist Partners has assembled a dynamic panel of Pharmaceutical Industry KOLs. The roundtable discussion will cover multiple industry-sensitive topics within the overall theme of "The Emerging Role of the Pharmacist: A Cutting Edge Approach". (Photo:...

2014-02-12 12:30:26

LONDON, Feb. 12, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Brazilian Pharmaceutical Market 2014-2024Report DetailsDrug selling in Brazil - this new analysis shows you trends, opportunities, and revenuesDo you want to assess the future of pharmaceuticals in Brazil? See what lies ahead, then. Visiongain's new report gives you revenue predictions, helping your work. There you discover financial results, trends, opportunities, and sales forecasts.So...

2014-02-11 12:26:53

MUMBAI, India, February 11, 2014 /PRNewswire/ -- Bharat Book Bureau presents Global Pharmaceutical & Biotechnology Outlook 2014: Japan Pharma. 2014 will be marked as a transition year for the Japanese Pharma industry - the year is bound to be painful both for innovators and generic companies due to the new regulations. We find these regulations to be 'decisive' in spurring generic penetration significantly, with the main beneficiary being the Japanese government (or...

2014-02-05 23:23:03

Global Pharmaceutical & Biotechnology Outlook 2014: Major US and EU report provide analysis of individual large cap companies, promising drug candidates in their late stage pipelines, competitive landscape, and important therapy areas. Dallas, Texas (PRWEB) February 05, 2014 Strategy Diversification Divested: Productivity measurements, Divestment of non-core assets resulting in a healthy Cash position- Will accelerate Next wave of targeted acquisition. In the recent years, several new...

2014-02-04 20:22:49

DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/vgwhc9/new_oral) has announced the addition of the "Concise Analysis of the International New Oral Anticoagulants Markets" [http://www.researchandmarkets.com/research/vgwhc9/new_oral ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Anticoagulants decrease the ability of the blood to create harmful blood clots that can...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related